Characterization of Plasmodium GAPDH as a candidate for development of a malaria pre-erythrocytic vaccine
疟原虫 GAPDH 作为开发疟疾前红细胞疫苗候选物的表征
基本信息
- 批准号:9228326
- 负责人:
- 金额:$ 24.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAntigen TargetingAntigensBindingBiological AssayBiteBlood CirculationBlood VesselsCell CommunicationCell Surface ReceptorsCellsCommunicable DiseasesCulicidaeDepositionDevelopmentDiseaseEconomicsEffectivenessEndothelial CellsEpitope MappingEpitopesErythrocytesGlyceraldehyde-3-Phosphate DehydrogenasesGlycolysisGlycosaminoglycansHepatocyteHumanImmuneImmunityImmunizationImmunizeImmunofluorescence ImmunologicIn VitroIndividualInfectionInsecticidesKupffer CellsLibrariesLigand BindingLigandsLiverMalariaMalaria VaccinesMass Spectrum AnalysisMeasuresMediatingMicrobeModelingMolecularMusParasitesPathogenicityPeptide Phage Display LibraryPeptide antibodiesPeptidesPersonsPhage DisplayPharmaceutical PreparationsPlasmodiumPlasmodium bergheiPlasmodium falciparumPlayProteinsReceptor CellRecombinantsSkinSporozoitesSurfaceTertiary Protein StructureTestingVaccine AntigenVaccinesWestern BlottingWorkcell typecircumsporozoite proteinexperimental studyfightingin vivokillingsliver infectionmacrophagemalaria infectionnovelphase III trialpublic health relevancereceptorstellate cellvector mosquitoweapons
项目摘要
DESCRIPTION (provided by applicant): Malaria remains one of the most devastating infectious diseases. It kills around a million people every year while causing immense suffering and economic losses worldwide. The two main weapons to fight the disease - insecticides that kill the mosquito vector and drugs that kill the parasites in infected individuals - significantly contribute to contain the disease. However, it is imperative that additional measures, such as vaccines, be developed for the elimination and eventual eradication of the disease. Human infection is initiated when during a bite by an infected mosquito, sporozoites are deposited in the
skin of the bitten person. Next, sporozoites enter the circulation and must leave it in the liver t continue their cycle. Liver vessels are lined by two cell types - endothelial cells and Kupffer cels - and sporozoites exit the vessels by preferentially traversing Kupffer cells. Using a phage peptide display library we have identified three peptides - P39, P61 and P52 - that bind specifically to Kupffer cells and by doing so, inhibit sporozoite traversal both in vitro (Kupffer ell cultures) and in vivo (live mice). Further work determined that the peptides bind to the CD68 Kupffer cell surface receptor protein. Moreover, the peptides structurally mimic domains of Plasmodium berghei glyceraldehyde 3-phosphate dehydrogenase (PbGAPDH), a protein present on the surface of sporozoites. In addition, we have shown that the CD68 and PbGAPDH proteins interact directly. This project aims at identifying domains of the PbGAPDH protein that mediate interactions with the CD68 receptor. These protein domains will be used as antigens to immunize mice. It is expected that the antibodies of immune mice will interfere with sporozoite traversal of Kupffer cells and in this way, thwart liver infection. The antigens identified in this
study may conceivably be used to enhance the effectiveness of the RTS,S pre-erythrocytic vaccine, which in phase III trials has proven to be partially effective.
描述(由申请人提供):疟疾仍然是最具破坏性的传染病之一。它每年造成约100万人死亡,同时在全世界造成巨大痛苦和经济损失。对抗这种疾病的两种主要武器--杀死蚊子媒介的杀虫剂和杀死感染者体内寄生虫的药物--对遏制这种疾病有很大的贡献。然而,必须制定更多的措施,如疫苗,以消除并最终根除这一疾病。当被受感染的蚊子叮咬期间,子孢子沉积在
被咬者的皮肤。其次,子孢子进入循环,必须离开它在肝脏继续他们的周期。肝血管由两种类型的细胞-内皮细胞和枯否细胞-内衬,子孢子通过优先穿过枯否细胞离开血管。使用噬菌体肽展示文库,我们已经鉴定了三种肽- P39、P61和P52 -其特异性结合枯否细胞,并且通过这样做,在体外(枯否细胞培养物)和体内(活小鼠)抑制子孢子穿越。进一步的工作确定了肽与CD 68 Kupffer细胞表面受体蛋白结合。此外,肽在结构上模拟伯氏疟原虫甘油醛3-磷酸脱氢酶(PbGAPDH)的结构域,所述蛋白质存在于子孢子表面上。此外,我们已经表明,CD 68和PbGAPDH蛋白直接相互作用。该项目旨在鉴定PbGAPDH蛋白介导与CD 68受体相互作用的结构域。这些蛋白质结构域将用作抗原以免疫小鼠。预期免疫小鼠的抗体将干扰库普弗细胞的子孢子穿越,并以这种方式阻止肝脏感染。本研究中鉴定的抗原
这项研究可以想象地用于增强RTS,S红细胞前疫苗的有效性,该疫苗在III期试验中已被证明是部分有效的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARCELO JACOBS-LORENA其他文献
MARCELO JACOBS-LORENA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARCELO JACOBS-LORENA', 18)}}的其他基金
2013 TROPICAL INFECTIOUS DISEASES: FROM BENCH TO FIELD GORDON RESEARCH CONFERENCE
2013 热带传染病:从实验室到现场戈登研究会议
- 批准号:
8452997 - 财政年份:2013
- 资助金额:
$ 24.3万 - 项目类别:
2011 Tropical Infectious Diseases Gordon Research Conference
2011年热带传染病戈登研究会议
- 批准号:
8119215 - 财政年份:2011
- 资助金额:
$ 24.3万 - 项目类别:
Reducing malaria transmission with engineered bacteria
利用工程细菌减少疟疾传播
- 批准号:
8137946 - 财政年份:2010
- 资助金额:
$ 24.3万 - 项目类别:
Reducing malaria transmission with engineered bacteria
利用工程细菌减少疟疾传播
- 批准号:
7869162 - 财政年份:2010
- 资助金额:
$ 24.3万 - 项目类别:
Vector biology-Using a mosquito pathogen as a delivery system for anti-malarial a
媒介生物学-使用蚊子病原体作为抗疟疾药物的传递系统
- 批准号:
7660719 - 财政年份:2009
- 资助金额:
$ 24.3万 - 项目类别:
相似海外基金
Development of novel ABO blood group antigen targeting peptide that suppress rejection during ABO-incompatible kidney transplantation
开发新型 ABO 血型抗原靶向肽,可抑制 ABO 不相容肾移植过程中的排斥反应
- 批准号:
23791736 - 财政年份:2011
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Antigen Targeting in plasmazytoide dendritische Zellen - Nutzung zur Toleranzinduktion und Vakzinierung
浆细胞样树突状细胞中的抗原靶向 - 用于耐受诱导和疫苗接种
- 批准号:
211908646 - 财政年份:2011
- 资助金额:
$ 24.3万 - 项目类别:
Research Grants
Development of Novel Prostate Specific Membrane Antigen Targeting Probes for Prostate Cancer Imaging
开发用于前列腺癌成像的新型前列腺特异性膜抗原靶向探针
- 批准号:
23791413 - 财政年份:2011
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Immunregulation bei entzündlichen Darmerkrankungen durch Antigen Targeting des DEC-205 Rezeptors - Mechanismen und Funktion
通过 DEC-205 受体抗原靶向调节炎症性肠病 - 机制和功能
- 批准号:
168824599 - 财政年份:2010
- 资助金额:
$ 24.3万 - 项目类别:
Research Grants
Anti-tumor vaccine by the use of antigen targeting to lectins expressed on dendritic cells
利用抗原靶向树突状细胞上表达的凝集素的抗肿瘤疫苗
- 批准号:
21790144 - 财政年份:2009
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of novel oncofetal antigen targeting immunotherapy for refractory ovarian carcinoma
难治性卵巢癌新型癌胎抗原靶向免疫疗法的开发
- 批准号:
21592127 - 财政年份:2009
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Salmonella type III-mediated antigen targeting to induce cellular immunity: characterzition of effector and memory T cell populations after oral vaccination
沙门氏菌 III 型介导的抗原靶向诱导细胞免疫:口服疫苗接种后效应和记忆 T 细胞群的特征
- 批准号:
5265936 - 财政年份:2000
- 资助金额:
$ 24.3万 - 项目类别:
Priority Programmes
TB ANTIGEN TARGETING TO ENHANCE T CELL RESPONSE
靶向结核抗原以增强 T 细胞反应
- 批准号:
2882120 - 财政年份:1999
- 资助金额:
$ 24.3万 - 项目类别:
TB ANTIGEN TARGETING TO ENHANCE T CELL RESPONSE
靶向结核抗原以增强 T 细胞反应
- 批准号:
2413472 - 财政年份:1998
- 资助金额:
$ 24.3万 - 项目类别:














{{item.name}}会员




